MeSH D017088 - aids-related opportunistic infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Acyclovir | Acyclovir |  | 1997-04-22 |  |  |
| Sulfamethoxazole, Trimethoprim | Cotrim |  | 1985-05-16 |  |  | |
| Sulfamethoxazole, Trimethoprim | Cotrim D.s |  | 1985-03-18 |  |  | |
| Fluconazole | Fluconazole |  | 2004-07-29 |  |  | |
| Pyrimethamine | Pyrimethamine |  | 2021-08-13 |  |  | |
| Sulfamethoxazole, Trimethoprim | Sulfamethoxazole Trimethoprim |  | 1991-10-31 |  |  | |
| Trimethoprim | Trimethoprim |  | 1987-06-18 |  |  | |
| Padagis | Acyclovir | Acyclovir |  | 2019-02-20 |  |  |
| Dapsone | Dapsone |  | 2023-11-01 |  |  | |
| Taro Pharmaceutical | Acyclovir | Acyclovir |  | 2016-12-21 |  |  |
| Dapsone | Dapsone |  | 2019-03-01 |  |  | |
| Fluconazole | Fluconazole |  | 2004-07-29 |  |  | |
| Glenmark Pharmaceuticals | Acyclovir | Acyclovir |  | 2017-07-31 |  |  |
| Fluconazole | Fluconazole |  | 2006-01-25 |  |  | |
| Sulfamethoxazole, Trimethoprim | Sulfamethoxazole Trimethoprim |  | 2010-12-22 |  |  | |
| Mylan | Acyclovir | Acyclovir |  | 1998-04-13 |  |  |
| Cidofovir | Cidofovir |  | 2012-06-27 |  |  | |
| Dapsone | Dapsone |  | 2022-02-04 |  |  | |
| Fluconazole | Fluconazole |  | 2004-07-29 |  |  | |
| Itraconazole | Itraconazole |  | 2012-07-20 |  |  | |
| Rifampin | Rifampin |  | 2008-05-22 |  |  | |
| Sulfamethoxazole, Trimethoprim | Sulfamethoxazole Trimethoprim |  | 2017-08-30 |  |  | |
| Acyclovir | Zovirax |  | 1985-01-25 |  |  | |
| Mayne Group | Itraconazole | Tolsura | 2023-07-25 | 2018-12-11 |  |  |
| Xiromed | Acyclovir | Acyclovir |  | 2020-01-29 |  |  |
| Johnson & Johnson | Itraconazole | Sporanox |  | 1992-09-11 |  |  |
| Almirall | Dapsone | Aczone | 2033-11-18 | 2016-02-24 |  |  |
1
2
3
4
5
6
...
12
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
94%16/17
Approved: 15Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use